18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery
NCT03821961 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2020-02-26
Summary
The aim of the study is to compare the endocrine function of pancreas between pre and post metabolic surgery in patients with type 2 diabetes or prediabetes. The study will examine the endocrine function of pancreas using 18F-FDOPA PET/CT imaging and various biochemical laboratory tests
Conditions
- Diabetes Mellitus, Type 2
- PreDiabetes
- Obesity
Interventions
- PROCEDURE
-
Metabolic Surgery
Roux-en-Y gastric bypass, Sleeve gastrectomy
Sponsors & Collaborators
-
Myungmoon Pharma. Co. Ltd.
collaborator INDUSTRY -
Korea University Anam Hospital
lead OTHER
Principal Investigators
-
Sungsoo Park, MD, PhD · Korea University Anam Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-03
- Primary Completion
- 2020-11-30
- Completion
- 2020-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms
NCT05709171 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
An Investigational Scan (MR DENSE) in Detecting Early Chemotherapy-Related Liver Injury Before Surgery in Patients With Resectable Colorectal Liver Metastases
NCT05059717 ·Status: WITHDRAWN ·Phase: NA
-
Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism
NCT05088798 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid Carcinoma
NCT03636945 ·Status: UNKNOWN ·Phase: NA
-
Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer
NCT03077334 ·Status: COMPLETED
-
A Repeatability Study of Fatty Acid Uptake Using PET/MR Imaging in Patients With T2DM and Non-diabetic Control Subjects
NCT05132335 ·Status: COMPLETED ·Phase: NA
-
Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin
NCT02856347 ·Status: COMPLETED ·Phase: NA
-
18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma
NCT06813742 ·Status: RECRUITING
-
Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling
NCT02944006 ·Status: UNKNOWN
-
Molecular Pituitary Imaging Using 18F-FET PET
NCT06584123 ·Status: RECRUITING ·Phase: NA
-
Multi-Tracer Pet Quantitation of Insulin Action
NCT00715221 ·Status: COMPLETED
-
Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)
NCT02539433 ·Status: COMPLETED ·Phase: NA
-
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
NCT07203495 ·Status: ACTIVE_NOT_RECRUITING
-
18F-FAPI PET Imaging in Pancreatic Adenocarcinoma
NCT05884463 ·Status: COMPLETED ·Phase: NA
-
68Ga-FAPI-FS PET/CT and PET/MR in Pancreatic Cancer
NCT05875753 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FDOPA PET in Neuroendocrine Tumours
NCT02431715 ·Status: NO_LONGER_AVAILABLE
-
A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma
NCT06277206 ·Status: COMPLETED
-
Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer
NCT00499395 ·Status: COMPLETED ·Phase: NA
-
18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study
NCT02938546 ·Status: UNKNOWN ·Phase: PHASE3
-
68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma
NCT05275985 ·Status: UNKNOWN ·Phase: NA
-
Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer
NCT01627704 ·Status: COMPLETED ·Phase: NA
-
Contrast-enhanced Diffusion-weighted MRI to Detect Liver Metastases in Patients With Pancreatic Cancer
NCT03469726 ·Status: UNKNOWN ·Phase: NA
-
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
NCT00904410 ·Status: COMPLETED ·Phase: PHASE4
-
Deuterium Metabolic MRI and [18F]FDG PET for Assessment of Treatment Response Following Radioembolization
NCT06232889 ·Status: RECRUITING ·Phase: NA
-
PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
NCT01395030 ·Status: COMPLETED ·Phase: PHASE2